Insight
Earnout Payments in Life Sciences and HealthTech M&A: Seller Beware
by Stephen Thau and Mike O'Donnell | September.26.2024
Earnout payments can be tricky. Learn about key negotiating tips and lessons from a recent case.
Insight
Texas Attorney General Reaches Novel Generative AI Settlement: What Health Tech Companies Need to Know
by Thora Johnson, Alyssa Wolfington, Amy M. Joseph, Jeremy D. Sherer, Emily Brodkin and Melania Jankowski | September.24.2024
The Texas Attorney General is once again signaling the office’s intent to enforce the state’s privacy and consumer protection laws.
Insight
Navigating University Technology Licensing for Startups: Key Considerations
by Stephen Thau and David Sharrow | September.23.2024
Licensing university technology to start a company is complex. Founders should be aware of key challenges and opportunities in the process.
Insight
Generative AI and Health Care: Key Takeaways
by Thora Johnson, Amy M. Joseph and Georgia C. Ravitz | September.20.2024
Generative AI is converging with every sector – and health care is no exception.
Insight
The EU AI Act: What Life Sciences and Digital Health Companies Should Know
by Julia Apostle, Daniel Kadin and David Sharrow | September.13.2024
EU AI Act is a landmark piece of legislation that establishes the first comprehensive framework for regulating the use of artificial intelligence.
Insight
Colorado Enacts Nation’s First Privacy Law to Protect Consumer Brainwaves: What it Means for Life Sciences and Health Tech Companies
by Thora Johnson and Peter Graham | May.01.2024
Legislators in Colorado have passed the first law in the United States meant to protect a consumer’s brainwaves.
Insight
Health Care Compliance: New Federal Guidance Seeks a Modernized Approach and Shows OIG’s Specific Interest in Private Equity and Tech Companies
by David Rhinesmith, Thora Johnson, Stephen Thau and Tony Chan | November.10.2023
The Department of Health and Human Services Office of Inspector General has issued new reference guide for the health care compliance community.
Insight
The Consumer Health Data Amendments to the Connecticut Data Privacy Act: Six Things to Know
by Thora Johnson, Alyssa Wolfington and Michaela Frai | July.24.2023
Connecticut is the third state to adopt consumer health data privacy protections. It is the first state, however, to embed broad protections for ...
Insight
U.S. Supreme Court’s Take on Section 230: What it Means for Online Platforms – and What’s Next
by Jacob M. Heath, Caroline Simons, Eric Shumsky, Meg Hennessey, Ciarra Carr and Shawn Maria Estrada | June.13.2023
The U.S. Supreme Court decided two cases recently that left untouched Section 230 of the Communications Decency Act.
Insight
What Healthcare Companies Need to Know and Do About Ad Tracking Technologies
by Thora Johnson, Hannah Levin and Alyssa Wolfington | March.14.2023
Healthcare companies track visitors to websites and mobile apps with third-party technologies like cookies and pixels, but that widespread practice ...
Insight
Antitrust Enforcement in Health Care: Increased Scrutiny Likely After DOJ Withdraws Policy Statements
by Eileen M Cole, Anna Aryankalayil and Craig Falls | February.17.2023
The Department of Justice recently withdrew three enforcement policy statements that had provided certain “safety zones” for dealings in health care.
Insight
Additional Considerations on IP Due Diligence for Prospective Investors of Emerging Life Sciences Companies
by Gargi Talukder, Jennifer Ng, Jessica Stern and Alex Straughn | December.15.2022
Following our first article on IP due diligence considerations for prospective investors of emerging life sciences companies, we’re taking an ...